Skip to search formSkip to main contentSkip to account menu

Hypercholesterolemia, Familial

Known as: Lipoproteinemia, Hyper-Low Density, Hyperlipoproteinemia Type II, Familial Hypercholesterolemic Xanthomatoses 
A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Objective: We tried to understand significance of increased triglyceride (TG) values in metabolic syndrome and coronary artery… 
Highly Cited
2009
Highly Cited
2009
. Platelet factor-3 activity and availability, platelet phospholipids, their fatty acid and aldehyde composition and plasma… 
Highly Cited
2009
Highly Cited
2009
Objective: To understand prognostic significance of white coat hypertension (WCH), and any its association with excess weight… 
1997
1997
BACKGROUND Molecular biology has improved the diagnostic abilities of physicians and enabled them to identify apparently healthy… 
Highly Cited
1987
Highly Cited
1987
DNA samples from 70 unrelated UK patients with heterozygous familial hypercholesterolaemia were screened by Southern blot… 
Highly Cited
1984
Highly Cited
1984
One hundred and sixteen patients with detrusor instability, detrusor hyper-reflexia or bladder hypersensitivity who had failed to… 
Highly Cited
1976
Highly Cited
1976
Bile acid-binding resins, currently used for the treatment of Type II hyperlipoproteinemia, decrease LDL cholesterol by 25 to 35… 
Highly Cited
1976
Highly Cited
1976
The rapid induction of cholesterol cholelithiasis in a new experimental model, the prairie dog, has recently been reported by two… 
Highly Cited
1975
Highly Cited
1975
In skin fibroblasts grown from four children with a homozygous form of type II hyperlipoproteinemia, the feedback control of…